Home/Filings/4/0001209191-23-050674
4//SEC Filing

Himawan Jeff 4

Accession 0001209191-23-050674

CIK 0001492426other

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 5:13 PM ET

Size

8.7 KB

Accession

0001209191-23-050674

Insider Transaction Report

Form 4
Period: 2023-09-26
Himawan Jeff
Director10% Owner
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-09-2632,1610 total
    Exercise: $13.87Exp: 2028-05-02Ordinary Shares (32,161 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2023-09-26$13.87/sh+32,161$446,07344,546 total
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    36,609
  • Ordinary Shares

    (indirect: By Foundation)
    7,873
Footnotes (2)
  • [F1]10,264 shares previously reported as held indirectly by Trust are now held directly.
  • [F2]The stock option is fully vested.

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001342821

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 5:13 PM ET
Size
8.7 KB